This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Call Buyers in Aetna: Options

By Jud Pyle, CFA, chief investment strategist for the Options News Network

Aetna (AET - Get Report) did not announce significant news today, but at least one investor is taking a bullish stance on the health insurance name and boosting call volume.

The slightly out-of-the-money Nov. 31 calls have changed hands more than 20,000 times so far today and are home to current open interest of 311 contracts. The bulk of these calls traded at a price near 95 cents around 11:10 a.m. EST, when the stock was around $28. That computes to an implied volatility of approximately 47, compared to the 63-day realized volatility of 42.

Given the premium of 95 cents, the buyer needs AET shares to expire higher than $31.95 to make money, unless of course, the calls rise prior to expiration following a rise in the shares and the investor chooses to sell them to take profit.

Shares of Aetna have slid along with other HMO stocks like Cigna (CI - Get Report) and WellPoint (WLP) over the last week and a half. AET and other stocks in the sector are down approximately 10% since the close on Sept. 21.

One catalyst this call buyer could be banking on to get the shares moving upward again is AET's earnings report. The company is currently scheduled to announce results for its fiscal third quarter before the market opens on Oct. 29. Analysts are anticipating the company will make 66 cents per share, down from $1.12 in the same quarter 2008.
1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AET $106.25 3.40%
CI $138.86 2.90%
WLP $136.01 1.43%
AAPL $117.33 -0.82%
FB $106.21 1.90%


Chart of I:DJI
DOW 17,813.19 +93.27 0.53%
S&P 500 2,092.32 +11.91 0.57%
NASDAQ 5,131.81 +23.1440 0.45%

Free Reports